Zobrazeno 1 - 10
of 40
pro vyhledávání: '"G. Chik"'
Publikováno v:
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 41:330-334
Background: We tested the hypothesis that serum apolipoprotein H (apo H) concentration increases after an oral fat load. Such a study would give valuable insight into whether apo H was influenced by the postprandial state. Methods: Ten male subjects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7a8b0abadf488c65cbaed299084b9df
https://doi.org/10.1258/0004563041201482
https://doi.org/10.1258/0004563041201482
Publikováno v:
International Journal of Clinical Practice. 58:465-468
Moxonidine is centrally acting imidazoline type-1 receptor agonist that significantly lowers blood pressure and has some insulin-sensitising actions. Its effects on plasma lipid profiles are uncertain. This study examined the effects of moxonidine on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8005b1611d11be94d133ce59e4bf82ef
https://doi.org/10.1111/j.1368-5031.2004.00158.x
https://doi.org/10.1111/j.1368-5031.2004.00158.x
Publikováno v:
QJM. 92:387-394
We compared atorvastatin with simvastatin-based therapies in a prospective observational study of 201 patients with severe hyperlipidaemia. Atorvastatin 10 mg therapy was substituted for simvastatin 20 mg, 20 mg for 40 mg, 40 mg for simvastatin 40 mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cdcbc0f59b4f915d84450eee7367a9f
https://doi.org/10.1093/qjmed/92.7.387
https://doi.org/10.1093/qjmed/92.7.387
Publikováno v:
International Journal of Clinical Practice. 59:3-5
Summary Ezetimibe is intestinally active cholesterol absorption inhibitor used to reduce low-density lipoprotein–cholesterol levels. This case report describes a novel side effect with this agent: ezetimibe-induced hyperlipidaemia in a patient with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21fd49b8ecbfc2a04176f3b0565973ce
https://doi.org/10.1111/j.1368-504x.2005.00423.x
https://doi.org/10.1111/j.1368-504x.2005.00423.x
Publikováno v:
IEEE Journal of Selected Topics in Quantum Electronics. 1:275-284
The magnitude of the temperature rate of change of the threshold current density (J/sub th/) is examined with respect to J/sub th/, for a variety of unstrained and strained, long wavelength multiple quantum-well (MQW) lasers. A strong correlation is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bb16f2de0c0eb8108b49914906c8de5
https://doi.org/10.1109/2944.401206
https://doi.org/10.1109/2944.401206
Autor:
G. Chik, Anthony J. SpringThorpe, G. Knight, Edward H. Sargent, Jimmy Xu, M. Cleroux, F.R. Shepherd, Agnes Margittai, D.A. Suda, N. Puetz, Toshi Makino
Publikováno v:
IEEE Photonics Technology Letters. 10:1536-1538
We report the design, fabrication, and characterization of lateral current injection (LCI) GaInAsP SQW lasers made using a single etch-and-regrowth followed by selective dopant diffusion. Devices are characterized electrically and optically from 10 t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b822ac827a3d596ed25873759ece381
https://doi.org/10.1109/68.726741
https://doi.org/10.1109/68.726741
Publikováno v:
International journal of clinical practice. Supplement. (147)
Ezetimibe is intestinally active cholesterol absorption inhibitor used to reduce low-density lipoprotein-cholesterol levels. This case report describes a novel side effect with this agent: ezetimibe-induced hyperlipidaemia in a patient with statin in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::36979a16c4b3e6eea50976bdedc17ecf
https://pubmed.ncbi.nlm.nih.gov/15963223
https://pubmed.ncbi.nlm.nih.gov/15963223
Publikováno v:
International journal of clinical practice. 58(5)
Moxonidine is centrally acting imidazoline type-1 receptor agonist that significantly lowers blood pressure and has some insulin-sensitising actions. Its effects on plasma lipid profiles are uncertain. This study examined the effects of moxonidine on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::be6905d6de9d362e2070f1cad364f098
https://pubmed.ncbi.nlm.nih.gov/15206502
https://pubmed.ncbi.nlm.nih.gov/15206502
Publikováno v:
International journal of clinical practice. 55(10)
High-dose preparations of simvastatin and atorvastatin have recently become available to treat resistant hypercholesterolaemia aggressively, but few studies have compared these two agents. This study compared the efficacy of simvastatin 80 mg and 120
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eca0e0b596591fcb01d05ad477dcf015
https://pubmed.ncbi.nlm.nih.gov/11777291
https://pubmed.ncbi.nlm.nih.gov/11777291
Publikováno v:
European journal of internal medicine. 12(6)
Elevated serum total sialic acid (TSA) has been shown to be associated with increased cardiovascular mortality. It has been postulated that atherogenesis is a postprandial phenomenon. We tested the hypothesis that serum TSA and other acute phase prot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::019c7d8684e7e35669283e58a585b707
https://pubmed.ncbi.nlm.nih.gov/11711274
https://pubmed.ncbi.nlm.nih.gov/11711274